Personalized Testing Options

to fit your every need

Confirmation Panels

Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.

  • 114 - Comprehensive Confirmation Panel
  • 115 - Basic confirmation Panel
  • 116 - Behavorial Health Confirmation Panel
  • 117 - Pain Management Confirmation Panel
  • 118 - Long-Term Monitoring Confirmation Panel

Qualitative Analysis

PremierTox qualtitative testing utilizes leading edge sensitivity for the identification of targeted drugs and drug classes. PremierTox qualitative analysis provides clinically relevant drug detection for enhanced compliance monitoring and improved patient outcomes.

  • 103 - UPT Urine Pregnancy Test
  • 128 - PremierTox Screen ZT
  • 129 - PremierTox 12 Panel Drug Screen
  • 136 - PremierTox 11x Panel Drug Screen

Reflex Analysis

Managing your patients' compliance with prescribed treatment is complex. Effective monitoring requires testing that's flexible to the individual needs of the patient, while precisely detecting PremierTox AutoReflex, is a recommended methodology for medically necessary compliance monitoring by most insurance companies, including Medicare.

  • 8128 - PremierTox AutoReflexZT
  • 8129 - PremierTox 12 AutoReflex
  • 8136 - PremierTox 11x AutoReflex
  • 9129 - 12 Panel Evaluation Screen
  • 9130 - 8 Panel Evaluation Screen

501 - Oral Fluid Quantitative Assay

The PremierTox Oral Fluid Quantitative Assay is a highly sophisticated test for drugs and metabolites in saliva. Our proprietary analytical methodology employs some of the most sensitive detection cut-offs in the industry to support your therapeutic drug monitoring needs when urine testing is not an available option.

Quantitative Analysis

Individual drugs or drug groups may be added to our proprietary panels or selected for independent analysis to ensure targeted quantification of drugs and their metabolites for clinical diagnosis and compliance monitoring.

  • 104 - ETG (Ethyl Glucuronide)
  • 106 - Methylphenidate Group
  • 107 - Amphetamine Group
  • 108 - Barbiturate Group
  • 109 - Benzodiadepine-Sedative Group
  • 110 - Buprenorphine Group
  • 111 - THC (marijuana)
  • 112 - Benzoylecgonine (Cocaine Metabolite)
  • 113 - Opioid Group
  • 119 - Illicit Group
  • 121 - Tapentadol Group
  • 122 - Gabapentin
  • 123 - Pregabalin
  • 124 - Carisoprodol Group
  • 125 - PCP
  • 126 - Ecstacy Group
  • 132 - Propoxyphene
  • 133 - Meperidine Group
  • 137 - Naloxone Group
  • 138 - Antidepressant Group
  • 139- Levorphanol
  • 155 - Synthetic Cannabinoids
  • 156 - Expanded Synthetic Cathinones
  • 162 - Mitragynine
  • 163 - Barbiturate Sub Group
  • 165 - Phentermine
  • 167 - Nicotine Group
  • 171 - Oxycodone Group
  • 172 - Fentanyl Group
  • 173 - Methadone Group
  • 174 - Naltrexone Group
  • 175 - 6-Acetylmorphine (Heroin Metabolite)
  • 176 - Tramadol Group
  • 177 - Alprazolam Group
  • 178 - Diazepam Group
  • 179 - 7-Aminoclonazepam
  • 180 - Lorazepam
  • 369 - Opiates Group
  • 370 - Benzodiazepine Select Group
  • ISOM - Methamphetamine d&l Isomer Testing

Choose PremierTox for Informed Decision Making

Proven Accuracy at low clinical cutoffs: results you can trust

Proprietary methodology at a reduced cost

Rapid turn around times that speed results back to your practice:
     screen results available same business day 
      final confirmation results available next business day

Clinical and toxicology expertise in real-time to help inform your treatment decisions

expert advice